These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 16388726)

  • 1. Significant changes of peripheral perfusion and plasma adrenomedullin levels in N-acetylcysteine long term treatment of patients with sclerodermic Raynauds phenomenon.
    Salsano F; Letizia C; Proietti M; Rossi C; Proietti AR; Rosato E; Pisarri S
    Int J Immunopathol Pharmacol; 2005; 18(4):761-70. PubMed ID: 16388726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oral N-acetylcysteine in the treatment of Raynaud's phenomenon secondary to systemic sclerosis: a randomized, double-blind, placebo-controlled clinical trial].
    Correa MJ; Mariz HA; Andrade LE; Kayser C
    Rev Bras Reumatol; 2014; 54(6):452-8. PubMed ID: 25458027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment with N-acetylcysteine of Raynaud's phenomenon and ischemic ulcers therapy in sclerodermic patients: a prospective observational study of 50 patients.
    Rosato E; Borghese F; Pisarri S; Salsano F
    Clin Rheumatol; 2009 Dec; 28(12):1379-84. PubMed ID: 19690939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: a pilot study.
    Sambo P; Amico D; Giacomelli R; Matucci-Cerinic M; Salsano F; Valentini G; Gabrielli A
    J Rheumatol; 2001 Oct; 28(10):2257-62. PubMed ID: 11669166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
    Stoyneva Z
    Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.
    Gardinali M; Pozzi MR; Bernareggi M; Montani N; Allevi E; Catena L; Cugno M; Bottasso B; Stabilini R
    J Rheumatol; 2001 Apr; 28(4):786-94. PubMed ID: 11327251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cold stimulus fingertip lacticemy test--an effective method to monitor acute therapeutic intervention on primary Raynaud's phenomenon and systemic sclerosis.
    Fontenelle SM; Kayser C; Pucinelli ML; Andrade LE
    Rheumatology (Oxford); 2008 Jan; 47(1):80-3. PubMed ID: 18077495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bosentan improves skin perfusion of hands in patients with systemic sclerosis with pulmonary arterial hypertension.
    Rosato E; Molinaro I; Borghese F; Rossi C; Pisarri S; Salsano F
    J Rheumatol; 2010 Dec; 37(12):2531-9. PubMed ID: 20810512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Laser Speckle Contrast Imaging to Assess Digital Microvascular Function in Primary Raynaud Phenomenon and Systemic Sclerosis: A Comparison Using the Raynaud Condition Score Diary.
    Pauling JD; Shipley JA; Hart DJ; McGrogan A; McHugh NJ
    J Rheumatol; 2015 Jul; 42(7):1163-8. PubMed ID: 26034146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
    Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal amplitude and kinetics of digital postocclusive reactive hyperemia in systemic sclerosis.
    Gaillard-Bigot F; Roustit M; Blaise S; Gabin M; Cracowski C; Seinturier C; Imbert B; Carpentier P; Cracowski JL
    Microvasc Res; 2014 Jul; 94():90-5. PubMed ID: 24990822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for increase in finger blood flow, evaluated by laser Doppler flowmetry, following iloprost infusion in patients with systemic sclerosis: a week-long observational longitudinal study.
    Rotondo C; Nivuori M; Chialà A; Praino E; Matucci Cerinic M; Cutolo M; Lapadula G; Iannone F
    Scand J Rheumatol; 2018 Jul; 47(4):311-318. PubMed ID: 29409385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital blood flow response to body warming, cooling, and rewarming in patients with Raynaud's phenomenon.
    Lau CS; Khan F; Brown R; McCallum P; Belch JJ
    Angiology; 1995 Jan; 46(1):1-10. PubMed ID: 7818151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
    Abou-Raya A; Abou-Raya S; Helmii M
    J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laser Doppler perfusion imaging in systemic sclerosis impaired response to cold stimulation involves digits and hand dorsum.
    Rosato E; Rossi C; Molinaro I; Giovannetti A; Pisarri S; Salsano F
    Rheumatology (Oxford); 2011 Sep; 50(9):1654-8. PubMed ID: 21622523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis.
    Rosato E; Letizia C; Proietti M; Aversa A; Menghi G; Rossi C; Torella E; Cotesta D; Petramala L; Bruzziches R; Spera G; Pisarri S; Salsano F
    J Biol Regul Homeost Agents; 2009; 23(1):23-9. PubMed ID: 19321043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laser Doppler perfusion imaging is useful in the study of Raynaud's phenomenon and improves the capillaroscopic diagnosis.
    Rosato E; Borghese F; Pisarri S; Salsano F
    J Rheumatol; 2009 Oct; 36(10):2257-63. PubMed ID: 19684154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood perfusion correlates with microvascular abnormalities in systemic sclerosis: a laser-Doppler and nailfold videocapillaroscopy study.
    Cutolo M; Ferrone C; Pizzorni C; Soldano S; Seriolo B; Sulli A
    J Rheumatol; 2010 Jun; 37(6):1174-80. PubMed ID: 20436070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitonin gene-related peptide in treatment of severe peripheral vascular insufficiency in Raynaud's phenomenon.
    Bunker CB; Reavley C; O'Shaughnessy DJ; Dowd PM
    Lancet; 1993 Jul; 342(8863):80-3. PubMed ID: 8100913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon.
    Kanetaka T; Komiyama T; Onozuka A; Miyata T; Shigematsu H
    Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):414-6. PubMed ID: 15015193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.